Hospital
Phc-Los Alamos INC
Phc-Los Alamos INC was paid $2.56M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoPHC-LOS ALAMOS INC
LOS ALAMOS, NM 87544
LOS ALAMOS, NM 87544
33aNPI1285701623assigned 11/29/2006
33bProvider typeRural Acute Care Hospital
28Total paid$2.56M
24GClaims57,123
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,403 | $570K | |
| 2019 | 7,215 | $303K | |
| 2020 | 3,603 | $182K | |
| 2021 | 6,092 | $277K | |
| 2022 | 8,036 | $431K | |
| 2023 | 9,959 | $442K | |
| 2024incomplete | 7,815 | $353K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 5,859 | 5,405 | $798K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 4,048 | 3,641 | $752K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.6% | 918 | 821 | $221K |
| 80053 | Comprehensive metabolic panel | 3.6% | 6,443 | 5,621 | $93K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 930 | 886 | $78K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 7,124 | 6,075 | $53K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.9% | 1,349 | 1,204 | $48K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.8% | 1,047 | 897 | $46K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 1,016 | 923 | $45K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 1,013 | 865 | $42K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 1,964 | 1,883 | $37K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 143 | 131 | $35K |
60 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 612 | $26K |
| 71045 | Radiologic examination, chest; single view | <1% | 603 | $25K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 437 | $21K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 848 | $20K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,942 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 324 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 315 | $16K |
| 80061 | Lipid panel | <1% | 1,450 | $15K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 220 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,061 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 179 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 288 | $9K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 119 | $8K |
| 81025 | <1% | 712 | $7K | |
| 83690 | <1% | 890 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 57 | $6K |
| 81001 | <1% | 1,075 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 303 | $6K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 108 | $5K |
| 81003 | <1% | 2,009 | $5K | |
| G0378 | Hospital observation service, per hour | <1% | 20 | $4K |
| 86140 | <1% | 696 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 165 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 465 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 260 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 202 | $3K |
| 84439 | <1% | 345 | $3K | |
| 84484 | <1% | 194 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,251 | $3K |
| 87430 | <1% | 212 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 102 | $3K |
| 87490 | <1% | 104 | $2K | |
| 85652 | <1% | 567 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 203 | $2K |
| 87590 | <1% | 87 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 50 | $2K |
| 73630 | <1% | 28 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 14 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,258 | $1K |
| 87081 | <1% | 171 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 47 | $1K |
| 87420 | <1% | 82 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 104 | $1K |
| H0049 | Alcohol and/or drug screening | <1% | 42 | $901.22 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 14 | $566.43 |
| 83735 | <1% | 104 | $505.15 | |
| 87186 | <1% | 42 | $327.82 | |
| 85610 | <1% | 98 | $321.71 | |
| J2704 | Injection, propofol, 10 mg | <1% | 96 | $276.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 117 | $250.27 |
| 97161 | <1% | 13 | $233.64 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 145 | $216.85 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 32 | $179.11 |
| 87077 | <1% | 28 | $164.27 | |
| A9270 | Non-covered item or service | <1% | 161 | $124.15 |
| 87070 | <1% | 13 | $118.60 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 131 | $95.62 |
| 82570 | <1% | 12 | $66.47 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 30 | $32.17 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 12 | $1.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.